Mapping UBE3A in Non‐Human Primates to Inform UBE3A Gene Therapy and Reinstatement Strategies to Treat Angelman Syndrome
Identifying UBE3A substrates targeted for proteasome degradation in human cortical neurons and their pathological importance in Angelman Syndrome